Anti-CD168 抗体 [EPR4055]
Anti-CD168 antibody [EPR4055]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal CD168 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 7 publications.
別名を表示する
CD168, IHABP, RHAMM, HMMR, Hyaluronan mediated motility receptor, Intracellular hyaluronic acid-binding protein, Receptor for hyaluronan-mediated motility
- WB
Unknown
Western blot - Anti-CD168 antibody [EPR4055] (AB108339)
All lanes:
Western blot - Anti-CD168 antibody [EPR4055] (ab108339) at 1/1000 dilution
Lane 1:
T47-D cell lysate at 10 µg
Lane 2:
MCF-7 cell lysate at 10 µg
Lane 3:
SKBR-3 cell lysate at 10 µg
Lane 4:
LnCaP cell lysate at 10 µg
Predicted band size: 84 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing positive staining in Normal stomach tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing positive staining in Normal tonsil tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing positive staining in Normal thymus tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 at 1/100 staining CD168 in paraffin-embedded human breast carcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing positive staining in Colonic adenocarcinoma tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 at 1/100 staining CD168 in paraffin-embedded human testis tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing negative staining in Normal liver tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4055] (AB108339)
ab108339 showing negative staining in Normal brain tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-CD168 antibody [EPR4055] (AB108339)
Purified ab108339 at 1/50 dilution (2μg) immunoprecipitating CD168 in T-47D whole cell lysate.
Lane 1 (input) : T-47D (Human ductal breast epithelial tumor epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab108339 + T-47D whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108339 in T-47D whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 85 kDa
All lanes:
Immunoprecipitation - Anti-CD168 antibody [EPR4055] (ab108339)
Predicted band size: 84 kDa
false
- WB
Lab
Western blot - Anti-CD168 antibody [EPR4055] (AB108339)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : Empty knockout HAP1 whole cell lysate (20 μg)
Lane 3 : CD168 whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab108339 observed at 90 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab108339 was shown to specifically react with CD168 when CD168 knockout samples were used. Wild-type and Empty knockout samples were subjected to SDS-PAGE. ab108339 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD168 antibody [EPR4055] (ab108339)
Predicted band size: 84 kDa
false
- WB
CiteAb
Western blot - Anti-CD168 antibody [EPR4055] (AB108339)
CD168 western blot using anti-CD168 antibody [EPR4055] ab108339. Publication image and figure legend from Picaud, L., Thibault, B., et al., 2014, J Ovarian Res, PubMed 24739440.
ab108339 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab108339 please see the product overview.
CD44 and CD168 expression in ovarian cancer cell lines. (A) The CD44 expression was measured by flow cytometry and analyzed with Cell Quest Pro software in ovarian cancer cell lines OVCAR-3, IGROV-1 and SKOV-3 as well as in REH lymphoblasts (negative control) and HeLa cells (positive controls). The auto fluorescence level was determined with an isotype control antibody (empty area). The CD44 expression was determined with an anti-CD44 antibody (full area) leading to the determination of the percentage of CD44 positive cells (M1). (B) The CD168 level was determined by western blot using a specific antibody in ovarian cancer cell lines OVCAR-3, IGROV-1 and SKOV-3 as well as in REH lymphoblasts and HeLa (positive controls). Immunocomplexes were visualized with a photon camera.
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-CD168 antibody [EPR4055] - BSA and Azide free
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hyaluronan-mediated motility receptor plays an important role in the regulation of the extracellular matrix (ECM) by binding to hyaluronan a significant component of the ECM. CD168 has a vital function in cell surface signaling processes facilitating communication between cells and their environment. The protein operates in a complex with elements like growth factor receptors enhancing its ability to modulate cellular responses. This interaction allows CD168 to significantly influence processes like wound healing and tissue remodeling.
Pathways
Hyaluronan-mediated motility receptor participates in the Rho signaling pathway important for cytoskeletal organization and cell movement. Through this pathway CD168 interacts directly with proteins such as GTPases including members of the Rho family like RhoA which play key roles in the reorganization of the actin cytoskeleton. CD168 also relates to the PI3K/AKT pathway influencing cellular survival and proliferation by interacting with proteins such as PI3K integrally involved in cellular growth and response to extracellular signals.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy oncolytics 23:277-287 PubMed34761107
2021
Applications
Unspecified application
Species
Unspecified reactive species
Pathology, research and practice 223:153486 PubMed34051513
2021
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 8:410-421 PubMed35116773
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 9:20941-20952 PubMed29765511
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 7:39957-39969 PubMed27220886
2016
Applications
IHC, WB
Species
Unspecified reactive species, Unspecified reactive species
Oncology letters 12:2555-2559 PubMed27698827
2016
Applications
IHC
Species
Human
Journal of ovarian research 7:40 PubMed24739440
2014
Applications
WB
Species
Human
Abcam product promise
関連製品
Alternative Product
Primary Antibodies
AB262942
Anti-CD168 antibody
primary-antibodies
cd168-antibody-ab262942
0
(0 reviews)
Alternative Product
Primary Antibodies
AB124729
Anti-CD168 antibody [EPR4054]
primary-antibodies
cd168-antibody-epr4054-ab124729
5
(2 reviews)
Alternative Product
Primary Antibodies
AB228482
Anti-CD168 antibody [EPR4054] - Low endotoxin, Azide free
primary-antibodies
cd168-antibody-epr4054-low-endotoxin-azide-free-ab228482
0
(0 reviews)
Alternative Product
Primary Antibodies
AB271887
Anti-CD168 antibody [EPR4054] - BSA and Azide free
primary-antibodies
cd168-antibody-epr4054-bsa-and-azide-free-ab271887
0
(0 reviews)
Alternative Version
Primary Antibodies
AB229447
Anti-CD168 antibody [EPR4055] - Low endotoxin, Azide free
primary-antibodies
cd168-antibody-epr4055-low-endotoxin-azide-free-ab229447
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com